London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thompi yes it is an uncomfortable truth to address. To lose one maybe, two careless ; but three well it reeks. Added to which it is a relatively small Board: Is K Keegan still part time?
I sold some today. The elephant in the room is getting bigger whilst as a shareholder I am kept in the dark.
I’ve invested 20k and like others am heavily in the red. Like others I see the potential.
I’m happy to hold for the long term. But it does bother me that we have lost three key board members in the space of six months. That doesn’t sit right with me. Why did DT sell shares when he was on the board if good news was on the horizon? Why has Dan left and with only a two week hand over? I would not want to leave a company if it was on the cusp of something big. Very strange
Ps. Scary, if you haven’t seen my research you wouldn’t have heard of the patent being published on 20th Feb, or Fleur Wood being employed as IR consultant, you wouldn’t know who ran Ebers, you wouldn’t be aware of Jo Holland filing cocrystal patents for Vectura.
Also you’d know that the link you posted was pointless as tranilast isn’t FDA approved.
Nuformix aren’t targeting fda approval and that’s not what bioavailability testing is about.
Scary, it’s 1.75m.
That doesn’t stop me questioning anything and anyone.
Soupdragon78
I’m surprised by your change in tact lately you still holding the 1.6mil?? :)
What i find interesting is your failure to understand the words ‘proving tech’ securing ‘IP’ ‘reforming a known drug’
I think you perhaps have alter motives currently and thats because you are guessing on the Labs not doing commercial works but thats your choice.
So for Nuformix to pass its first drug to clear all the way to market using its tech proves the value. Changing the format of delivery by cleverly altering its properties and then delivering it to fit the bio equivalent % was very good indeed.
It highlights why changing Tranalist on NXP002 being altered so now its in a format for inhalation is exactly what we are excited about.
https://www.ipwatchdog.com/2014/10/19/the-high-cost-of-making-pharmaceuticals/id=51737/
And so Pettycash.... I mean Zoyatheeggy.com returns
Soupdragon78 - can’t say I’ve ever seen any of your research on here! Just bickering and negativity!
Anyway good luck with your investment whatever price you decide to get in
Scary, ok I’ll put it another way.
You said 95% of pharma’s fail the same test that NFX passed, can you tell me how you fail a bioavailability test?
I post my research here, I just find it odd why others don’t but expect people to believe them.
I’ve done my research, spoken to and discussed with quite a few people and am happy to hold.
Soupdragon78- it’s clear what ever I post positive about NFX you’ll have an excuse to rip my post apart which is why I’d rather keep my knowledge to myself!
Or either in or out and it’s clear what your agenda is
Exactly Soup.
Regarding income, it's just a matter of waiting probably 3 or 4 weeks for a good read.
Ebbers deal payments upto, so no clear idea of payments there atm.
No point in talking about the Chinese monies.
VistaGen . Who knows.
So let's see if we are in a good financial position as stated previously by the board.
Other news over the coming months???
Scary, you clearly don’t know what tests the company did on NXP001 last year by that statement.
SD78 - Let me explain why 2p prior to Ebers 51 million deal of ongoing payments and milestones.
The FACT NFX Passed CINV NXP001 drug last year something 95% of pharmaceutical companies fail on.
NFX passed it first time proving the technology.
They secured more patents and potential on NXP002 with a major deal potentially just around the corner.
They now have 100% world rights again on NXP001 with it being passed. Therefore its worth many millions more with a potential deal coming.
With other leads and news brewing on the major potential on NXP002 and NXP004 its clearly asset rich and moved a long long way from those levels.
So lets wait and see but I know what value is coming here soon
I'm happy to increase my holding along the way
So if it’s a so called similar pattern are we heading back to 2.5p then?
Scary. If everyone is so far off the mark, why not tell us what and where the mark is?
I'm very comfortable here
This reminds me of last year before it moved from 2.5p to 14.8p. Just saying ..... fun reading everyone’s post!
A lot of you guys are so far off the mark It’s embarrassing to read. Funny though.
Patience will pay off here.
Good luck to all especially the lth who have been through this before